Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Wing-Pui Kong

3PUBLICATIONS

23CO-AUTHORS

Innate immunityMedical infection agents (incl. prions)Nutritional epidemiology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Aug 28, 2025

Systemic and Mucosal Humoral Immune Responses to Lumazine Synthase 60-mer Nanoparticle SARS-CoV-2 Vaccines.

Cheng Cheng, Jeffrey C Boyington, Edward K Sarfo

|Nov 11, 2024

Structure-based design of glycoprotein subunit vaccines for mumps.

Rebecca J Loomis, Yen-Ting Lai, Sun B Sowers

|May 17, 2023

EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination.

Peter W Krug, Lingshu Wang, Wei Shi

Pageof 1

Frequent Collaborators

2 joint publications

Barney S Graham

2 joint publications

Tracy J Ruckwardt

1 joint publications

Peter W Krug

1 joint publications

Lingshu Wang

1 joint publications

Daniel L Moss

1 joint publications

Eun Sung Yang

1 joint publications

Kaitlyn M Morabito

1 joint publications

Masaru Kanekiyo

1 joint publications

Rebecca J Loomis

1 joint publications

Sun B Sowers

Frequent Collaborators

2 joint publications

Barney S Graham

2 joint publications

Tracy J Ruckwardt

1 joint publications

Peter W Krug

1 joint publications

Lingshu Wang

Top Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on : Aug 21, 2019

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on : Feb 10, 2022

See more related videos

Top Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of <em>E. coli</em>-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on : Aug 21, 2019

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on : Feb 10, 2022

See more related videos